These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 17455416)

  • 1. XDR-TB--danger ahead.
    Singh MM
    Indian J Tuberc; 2007 Jan; 54(1):1-2. PubMed ID: 17455416
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug-resistant tuberculosis: standardized or individualized treatment? The question has already been answered.
    Laniado-Laborín R
    Expert Rev Respir Med; 2010 Apr; 4(2):143-6. PubMed ID: 20406077
    [No Abstract]   [Full Text] [Related]  

  • 4. XDR-TB danger ahead.
    Behera D
    Indian J Tuberc; 2007 Apr; 54(2):99; author reply 99. PubMed ID: 17577914
    [No Abstract]   [Full Text] [Related]  

  • 5. XDR-TB danger ahead.
    Chauhan LS
    Indian J Tuberc; 2007 Apr; 54(2):99; author reply 99. PubMed ID: 17575682
    [No Abstract]   [Full Text] [Related]  

  • 6. Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?
    Gupta R; Raviglione MC; Espinal MA
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1078-9. PubMed ID: 11769764
    [No Abstract]   [Full Text] [Related]  

  • 7. Extensively drug-resistant tuberculosis: new strains, new challenges.
    Banerjee R; Schecter GF; Flood J; Porco TC
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thai drug-resistant tuberculosis predictive scores.
    Boonsarngsuk V; Tansirichaiya K; Kiatboonsri S
    Singapore Med J; 2009 Apr; 50(4):378-84. PubMed ID: 19421681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mini epidemic of isoniazide resistant TB in rural TN: a need for supervised preventive therapy.
    Mehta J; Keith R; Al Hasan M; Ryland B; Roy T
    Tenn Med; 2009 Aug; 102(8):41-4. PubMed ID: 19691201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Emergence extensive drug resistance tuberculosis (XDR)].
    Vier H; Schaberg T; Gillissen A
    Pneumologie; 2007 Sep; 61(9):606-9. PubMed ID: 17729211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia.
    Sar B; Keo C; Leng C; Saman M; Min DC; Chan S; Monchy D; Sarthou JL
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):104-7. PubMed ID: 19323041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 13. Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases.
    Sneag DB; Schaaf HS; Cotton MF; Zar HJ
    Pediatr Infect Dis J; 2007 Dec; 26(12):1142-6. PubMed ID: 18043453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Break through multidrug-resistant TB.
    Gribble EA; Williams A
    Nurse Pract; 2010 Mar; 35(3):14-22; quiz 22-3. PubMed ID: 20164730
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
    Kononets AS
    Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, control and treatment of multidrug-resistant tuberculosis.
    Chaulet P; Raviglione M; Bustreo F
    Drugs; 1996; 52 Suppl 2():103-7; discussion 107-8. PubMed ID: 8869846
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
    Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
    Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool.
    Migliori GB; Sotgiu G; Jaramillo E; Mirzayev F; Centis R; Colvin C; Richardson MD
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1305-8. PubMed ID: 19793438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The threat of extensively drug-resistant tuberculosis.
    Mohapatra PR
    Clin Infect Dis; 2007 Mar; 44(6):888-9. PubMed ID: 17304469
    [No Abstract]   [Full Text] [Related]  

  • 20. Reporting on multidrug-resistant tuberculosis: a proposed definition for the treatment outcome 'failed'.
    Chiang CY; Caminero JA; Enarson DA
    Int J Tuberc Lung Dis; 2009 May; 13(5):548-50. PubMed ID: 19383184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.